STOCK TITAN

Nexgel Inc Wt Exp 120126 SEC Filings

NXGLW NASDAQ

Welcome to our dedicated page for Nexgel Wt Exp 120126 SEC filings (Ticker: NXGLW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission (SEC) filings related to NEXGEL, Inc. (NASDAQ: NXGL, warrants: NXGLW). Through these documents, investors can review how the company reports its financial condition, capital structure, governance decisions and material events in an official regulatory format.

NEXGEL’s periodic reports, such as Forms 10-K and 10-Q, contain audited or reviewed financial statements, including balance sheets, statements of operations and cash flows, along with management’s discussion of revenue from contract manufacturing and consumer branded products, gross profit, operating expenses and net loss. These filings also provide details on assets such as cash, inventory, goodwill, intangibles and property and equipment, and on liabilities including accounts payable, notes payable and lease obligations.

The company’s current reports on Form 8-K document specific material events. Recent 8-K filings describe the release of quarterly financial results and related investor presentations, the entry into subscription agreements for a registered direct offering and concurrent private placement of unregistered warrants, and additional private placement transactions with accredited investors. Other 8-Ks report on the expansion of NEXGEL’s partnership with STADA Arzneimittel AG and on the outcomes of the 2025 Annual Meeting of Stockholders, including director elections, amendments to the 2019 Long-Term Incentive Plan, advisory votes on executive compensation and the ratification of the independent auditor.

Filings related to equity and warrant issuances outline the terms of registered offerings, private placements and unregistered warrants, including exercise prices, terms, beneficial ownership limitations and registration obligations for warrant shares. These documents also describe the role and compensation of placement agents and the use of exemptions from registration under the Securities Act.

On this page, Stock Titan pairs the raw SEC filings with AI-powered summaries that highlight key points, such as changes in capital structure, outcomes of shareholder votes, and the nature of material agreements. Users can quickly identify which filings contain quarterly results, which relate to financings or partnerships, and which address governance and compensation matters, while still having direct access to the full text as filed on EDGAR.

Rhea-AI Summary

NEXGEL, Inc. entered into a financing arrangement with an institutional investor for a 10% original issue discount convertible note facility of up to $56,667,667. The company has already issued Series A senior secured convertible notes with an original principal amount of $1,797,381, providing gross proceeds of $1,797,381.

The Series A proceeds are subject to a deposit account control agreement and are to be used primarily for an approved acquisition; the funds will be returned to the investor if the acquisition is not consummated. If the approved acquisition closes by April 15, 2026 and other conditions are met, the investor must purchase Series B notes in up to $14,869,286 for the acquisition.

The notes bear 10% annual interest, rising to 18% upon default, mature two years after issuance, and are senior secured by substantially all company assets. Series A notes convert at $1.244 per share, with alternative conversion prices based on VWAP and a floor price of $0.2488 per share, and issuance of Series B notes depends on stockholder approval of redomestication, reverse splits, an increase in authorized common shares to 250,000,000, and Nasdaq-related approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

NexGel, Inc. is offering up to $1,797,381 aggregate principal amount of Series A senior secured convertible notes and the common shares issuable upon their conversion. The notes bear 10% annual interest, mature on February 10, 2028, and can convert at a fixed $1.244 per share or an alternate price based on recent VWAP, subject to a floor.

The notes are secured obligations ranking senior to substantially all other indebtedness and include a 4.99% beneficial ownership cap, which investors may increase to 9.99% with notice. NexGel expects net proceeds of about $1,617,642, to be held under a deposit account control agreement and used primarily for a specified acquisition and related investor expenses, with strict limits on other uses.

If the approved acquisition closes by April 15, 2026, the investor must purchase an additional $14,869,286 of Series B senior secured convertible notes in a private offering for the same acquisition. NexGel’s common shares outstanding were 8,143,133 as of February 9, 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

NexGel, Inc. reported that board member Nachum Stein has notified the company of his intent to resign from its Board of Directors, effective February 2, 2026. He currently serves as Chairperson of the Board’s Compensation Committee and is leaving to lighten his schedule and focus on other business ventures.

The company states that Mr. Stein’s resignation is not due to any disagreement with NexGel or its subsidiaries on operations, policies, or practices. His resignation letter dated January 29, 2026 is included as Exhibit 17.1 to this report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

Adam R. Levy, Chief Executive Officer and a director of NexGel, Inc. (NXGL), reported a sale of 4,000 shares of common stock on 08/28/2025 at a weighted average price of $2.4741 per share. The filing states the sale was made for tax planning purposes. After the transaction, Mr. Levy beneficially owned 358,284 shares. The shares sold were originally acquired from the issuer on October 15, 2019. The report commits to provide specific per-price share counts if requested by the SEC, the issuer, or a security holder.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Form 144 notice for NexGel, Inc. (NXGLW) reports a proposed sale of 4,000 common shares through Charles Schwab with an aggregate market value of $9,800, scheduled approximately for 08/28/2025. The filing states the company has 8,067,580 shares outstanding, and the shares to be sold were acquired on 10/15/2019 via founder shares, a PIPE, ESOP and open market purchases.

The filer also discloses recent sales by the same person totaling 8,000 shares across five transactions from 05/30/2025 to 06/11/2025 with gross proceeds ranging from $2,218 to $4,779. The notice includes the required representation that the seller has no undisclosed material adverse information and a signature/attestation section. Several standard filer fields (CIK, contact details) are not populated in the provided text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

NexGel reported consolidated revenue of $2.884 million for the quarter ended June 30, 2025, up from $1.440 million a year earlier, and $5.690 million for the six months versus $2.706 million in 2024. Growth was driven largely by its consumer branded products, which produced $1.884 million in the quarter (vs. $968 thousand) and $3.666 million for six months (vs. $1.585 million).

Despite revenue gains, NexGel remains unprofitable: net loss attributable to NexGel stockholders was $1.377 million for the six months and the company used $807 thousand in operating cash over the period. Cash on hand was $725 thousand at June 30, 2025 and working capital was about $1.8 million, which the company says raises substantial doubt about its ability to continue as a going concern. Management is pursuing expanded sales channels, product development and possible financing to address liquidity needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
Rhea-AI Summary

NexGel, Inc. furnished a press release reporting the Companys results for the quarter ended June 30, 2025, attached as Exhibit 99.1, and disclosed a new investor presentation attached as Exhibit 99.2.

The filing states these materials are being furnished (not "filed") for purposes of the Exchange Act and therefore are not automatically incorporated by reference into other securities filings. The cover information lists the Companys common stock and warrants trading on The Nasdaq Capital Market under the symbols NXGL and NXGLW, and indicates the Company is an emerging growth company.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Nexgel Wt Exp 120126 (NXGLW)?

The current stock price of Nexgel Wt Exp 120126 (NXGLW) is $0.15 as of March 2, 2026.

NXGLW Rankings

NXGLW Stock Data

2.07M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
LANGHORNE

NXGLW RSS Feed